Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Whole-Cell Patch-Clamp Electrophysiology to Study Ionotropic Glutamatergic Receptors and Their Roles in Addiction.

Leyrer-Jackson JM, Olive MF, Gipson CD.

Methods Mol Biol. 2019;1941:107-135. doi: 10.1007/978-1-4939-9077-1_9.

PMID:
30707431
2.

Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking.

Powell GL, Leyrer-Jackson JM, Goenaga J, Namba MD, Piña J, Spencer S, Stankeviciute N, Schwartz D, Allen NP, Del Franco AP, McClure EA, Olive MF, Gipson CD.

Physiol Rep. 2019 Jan;7(1):e13958. doi: 10.14814/phy2.13958.

3.

Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Leyrer-Jackson JM, Nagy EK, Olive MF.

Psychopharmacology (Berl). 2018 Oct 27. doi: 10.1007/s00213-018-5067-5. [Epub ahead of print] Review.

PMID:
30368582
4.

Preface.

Tomek SE, Olive MF.

Int Rev Neurobiol. 2018;140:xi-xv. doi: 10.1016/S0074-7742(18)30098-9. No abstract available.

PMID:
30193711
5.

Social Influences in Animal Models of Opiate Addiction.

Tomek SE, Olive MF.

Int Rev Neurobiol. 2018;140:81-107. doi: 10.1016/bs.irn.2018.07.004. Epub 2018 Jul 30. Review.

PMID:
30193710
6.

Effects of heroin on rat prosocial behavior.

Tomek SE, Stegmann GM, Olive MF.

Addict Biol. 2019 Jul;24(4):676-684. doi: 10.1111/adb.12633. Epub 2018 May 4.

PMID:
29726093
7.

DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp JW, Rawls SM, Olive MF.

ACS Chem Neurosci. 2018 Oct 17;9(10):2379-2394. doi: 10.1021/acschemneuro.8b00147. Epub 2018 May 11.

PMID:
29714473
8.

Designer drugs - A continuing chemical (R)evolution.

Taffe MA, Olive MF.

Neuropharmacology. 2018 May 15;134(Pt A):1-3. doi: 10.1016/j.neuropharm.2018.03.037. Epub 2018 Mar 29. No abstract available.

PMID:
29605651
9.

The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms.

Namba MD, Tomek SE, Olive MF, Beckmann JS, Gipson CD.

Front Behav Neurosci. 2018 Feb 9;12:17. doi: 10.3389/fnbeh.2018.00017. eCollection 2018. Review.

10.

Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Sewalia K, Watterson LR, Hryciw A, Belloc A, Ortiz JB, Olive MF.

Neuropharmacology. 2018 May 15;134(Pt A):36-45. doi: 10.1016/j.neuropharm.2017.11.034. Epub 2017 Nov 26.

11.

The effect of litter separation on methamphetamine-conditioned place preference in post-partum dams.

Lewis CR, Baker AN, Fennig P, Conrad P, Hess L, Bastle RM, Olive MF.

Behav Pharmacol. 2017 Sep;28(6):489-492. doi: 10.1097/FBP.0000000000000317.

12.

Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.

Garcia R, Cotter AR, Leslie K, Olive MF, Neisewander JL.

Int J Neuropsychopharmacol. 2017 Aug 1;20(8):644-653. doi: 10.1093/ijnp/pyx025. Erratum in: Int J Neuropsychopharmacol. 2018 Oct 1;21(10):978.

13.

Calcium-permeable AMPA receptors and silent synapses in cocaine-conditioned place preference.

Shukla A, Beroun A, Panopoulou M, Neumann PA, Grant SG, Olive MF, Dong Y, Schlüter OM.

EMBO J. 2017 Feb 15;36(4):458-474. doi: 10.15252/embj.201695465. Epub 2017 Jan 11.

14.

Opposite Effects of mGluR1a and mGluR5 Activation on Nucleus Accumbens Medium Spiny Neuron Dendritic Spine Density.

Gross KS, Brandner DD, Martinez LA, Olive MF, Meisel RL, Mermelstein PG.

PLoS One. 2016 Sep 12;11(9):e0162755. doi: 10.1371/journal.pone.0162755. eCollection 2016.

15.

Structural and functional plasticity of dendritic spines - root or result of behavior?

Gipson CD, Olive MF.

Genes Brain Behav. 2017 Jan;16(1):101-117. doi: 10.1111/gbb.12324. Epub 2016 Oct 2. Review.

16.

Protein kinase Cɛ activity regulates mGluR5 surface expression in the rat nucleus accumbens.

Schwendt M, Olive MF.

J Neurosci Res. 2017 Apr;95(4):1079-1090. doi: 10.1002/jnr.23868. Epub 2016 Aug 21.

17.

Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.

Watterson LR, Olive MF.

Curr Top Behav Neurosci. 2017;32:133-143. doi: 10.1007/7854_2016_33. Review.

PMID:
27431398
18.

Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).

Watterson E, Spitzer A, Watterson LR, Brackney RJ, Zavala AR, Olive MF, Sanabria F.

Behav Brain Res. 2016 Oct 1;312:333-40. doi: 10.1016/j.bbr.2016.06.050. Epub 2016 Jun 27.

19.

Interactions between Early Life Stress, Nucleus Accumbens MeCP2 Expression, and Methamphetamine Self-Administration in Male Rats.

Lewis CR, Bastle RM, Manning TB, Himes SM, Fennig P, Conrad PR, Colwell J, Pagni BA, Hess LA, Matekel CG, Newbern JM, Olive MF.

Neuropsychopharmacology. 2016 Nov;41(12):2851-2861. doi: 10.1038/npp.2016.96. Epub 2016 Jun 17.

20.

Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats.

Watterson LR, Kufahl PR, Taylor SB, Nemirovsky NE, Olive MF.

J Drug Alcohol Res. 2016 May;5. pii: 235967. doi: 10.4303/jdar/235967.

21.

Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.

Burrows BT, Watterson LR, Johnson MA, Olive MF.

J Drug Alcohol Res. 2015 Dec;4. pii: 235958. Epub 2015 Dec 29.

22.

Chronic variable stress and intravenous methamphetamine self-administration - Role of individual differences in behavioral and physiological reactivity to novelty.

Taylor SB, Watterson LR, Kufahl PR, Nemirovsky NE, Tomek SE, Conrad CD, Olive MF.

Neuropharmacology. 2016 Sep;108:353-63. doi: 10.1016/j.neuropharm.2016.05.003. Epub 2016 May 7.

23.

Early life stress and chronic variable stress in adulthood interact to influence methamphetamine self-administration in male rats.

Lewis CR, Staudinger K, Tomek SE, Hernandez R, Manning T, Olive MF.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):182-4. doi: 10.1097/FBP.0000000000000166.

24.

Editorial: structural plasticity induced by drugs of abuse.

Olive MF, Gass JT.

Front Pharmacol. 2015 May 15;6:88. doi: 10.3389/fphar.2015.00088. eCollection 2015. No abstract available.

25.

Neurokinin-1 (NK₁) receptor antagonists as possible therapeutics for psychostimulant use disorders.

Olive MF.

CNS Neurol Disord Drug Targets. 2015;14(6):700-6. Review.

PMID:
26022261
26.

Nicotine-induced place conditioning and locomotor activity in an adolescent animal model of attention deficit/hyperactivity disorder (ADHD).

Watterson E, Daniels CW, Watterson LR, Mazur GJ, Brackney RJ, Olive MF, Sanabria F.

Behav Brain Res. 2015 Sep 15;291:184-188. doi: 10.1016/j.bbr.2015.05.031. Epub 2015 May 22.

27.

mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex.

LaCrosse AL, Taylor SB, Nemirovsky NE, Gass JT, Olive MF.

CNS Neurol Disord Drug Targets. 2015;14(4):476-85.

28.

Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation "bath salts," on intracranial self-stimulation thresholds in rats.

Watterson LR, Burrows BT, Hernandez RD, Moore KN, Grabenauer M, Marusich JA, Olive MF.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu014. doi: 10.1093/ijnp/pyu014.

29.

Synthetic cathinones and their rewarding and reinforcing effects in rodents.

Watterson LR, Olive MF.

Adv Neurosci (Hindawi). 2014 Jun 4;2014:209875.

30.

The development of acamprosate as a treatment against alcohol relapse.

Kufahl PR, Watterson LR, Olive MF.

Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26. Review.

31.

Chronic stress may facilitate the recruitment of habit- and addiction-related neurocircuitries through neuronal restructuring of the striatum.

Taylor SB, Anglin JM, Paode PR, Riggert AG, Olive MF, Conrad CD.

Neuroscience. 2014 Nov 7;280:231-42. doi: 10.1016/j.neuroscience.2014.09.029. Epub 2014 Sep 19.

32.

Early-life stress interactions with the epigenome: potential mechanisms driving vulnerability toward psychiatric illness.

Lewis CR, Olive MF.

Behav Pharmacol. 2014 Sep;25(5-6):341-51. doi: 10.1097/FBP.0000000000000057. Review.

33.

mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task.

LaCrosse AL, Burrows BT, Angulo RM, Conrad PR, Himes SM, Mathews N, Wegner SA, Taylor SB, Olive MF.

Psychopharmacology (Berl). 2015 Jan;232(1):251-8. doi: 10.1007/s00213-014-3653-8. Epub 2014 Jun 29.

34.

Enhancement of extinction learning attenuates ethanol-seeking behavior and alters plasticity in the prefrontal cortex.

Gass JT, Trantham-Davidson H, Kassab AS, Glen WB Jr, Olive MF, Chandler LJ.

J Neurosci. 2014 May 28;34(22):7562-74. doi: 10.1523/JNEUROSCI.5616-12.2014.

35.

Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.

Koneru R, Olive MF, Tyor WR.

J Neurovirol. 2014 Feb;20(1):9-17. doi: 10.1007/s13365-013-0223-5. Epub 2014 Jan 11.

PMID:
24415129
36.

Are AMPA receptor positive allosteric modulators potential pharmacotherapeutics for addiction?

Watterson LR, Olive MF.

Pharmaceuticals (Basel). 2013 Dec 30;7(1):29-45. doi: 10.3390/ph7010029.

37.

Positive or negative allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) does not alter expression of behavioral sensitization to methamphetamine.

Kufahl PR, Nemirovsky NE, Watterson LR, Zautra N, Olive MF.

F1000Res. 2013 Mar 12;2:84. doi: 10.12688/f1000research.2-84.v1. eCollection 2013.

38.

NMDA Receptor Modulators in the Treatment of Drug Addiction.

Tomek SE, Lacrosse AL, Nemirovsky NE, Olive MF.

Pharmaceuticals (Basel). 2013 Feb 6;6(2):251-68. doi: 10.3390/ph6020251.

39.

Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving.

Loweth JA, Scheyer AF, Milovanovic M, LaCrosse AL, Flores-Barrera E, Werner CT, Li X, Ford KA, Le T, Olive MF, Szumlinski KK, Tseng KY, Wolf ME.

Nat Neurosci. 2014 Jan;17(1):73-80. doi: 10.1038/nn.3590. Epub 2013 Nov 24.

40.

The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"

Watterson LR, Hood L, Sewalia K, Tomek SE, Yahn S, Johnson CT, Wegner S, Blough BE, Marusich JA, Olive MF.

J Addict Res Ther. 2012 Dec 1;Suppl 9. pii: 002.

41.

Constitutive knockout of kalirin-7 leads to increased rates of cocaine self-administration.

Kiraly DD, Nemirovsky NE, LaRese TP, Tomek SE, Yahn SL, Olive MF, Eipper BA, Mains RE.

Mol Pharmacol. 2013 Oct;84(4):582-90. doi: 10.1124/mol.113.087106. Epub 2013 Jul 26.

42.

Abuse liability of novel 'legal high' designer stimulants: evidence from animal models.

Watterson LR, Watterson E, Olive MF.

Behav Pharmacol. 2013 Sep;24(5-6):341-55. doi: 10.1097/FBP.0b013e3283641ec8. Review.

PMID:
23839028
43.

The Effects of Maternal Separation on Adult Methamphetamine Self-Administration, Extinction, Reinstatement, and MeCP2 Immunoreactivity in the Nucleus Accumbens.

Lewis CR, Staudinger K, Scheck L, Olive MF.

Front Psychiatry. 2013 Jun 17;4:55. doi: 10.3389/fpsyt.2013.00055. eCollection 2013.

44.

Neuropeptide systems and schizophrenia.

LaCrosse AL, Olive MF.

CNS Neurol Disord Drug Targets. 2013 Aug;12(5):619-32. Review.

PMID:
23574175
45.

Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Yahn SL, Watterson LR, Olive MF.

Subst Abuse. 2013;6:1-12. doi: 10.4137/SART.S9345. Epub 2013 Jan 31.

46.

Similar ethanol drinking in adolescent and adult C57BL/6J mice after chronic ethanol exposure and withdrawal.

Carrara-Nascimento PF, Lopez MF, Becker HC, Olive MF, Camarini R.

Alcohol Clin Exp Res. 2013 Jun;37(6):961-8. doi: 10.1111/acer.12056. Epub 2013 Jan 8.

47.

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans.

Taylor SB, Lewis CR, Olive MF.

Subst Abuse Rehabil. 2013 Feb 8;4:29-43. doi: 10.2147/SAR.S39684. eCollection 2013. Review.

48.

Increases in doublecortin immunoreactivity in the dentate gyrus following extinction of heroin-seeking behavior.

Hicks MP, Wischerath KC, Lacrosse AL, Olive MF.

Neural Plast. 2012;2012:283829. doi: 10.1155/2012/283829. Epub 2012 Nov 1.

49.

Positive Allosteric Modulation of mGluR5 Accelerates Extinction Learning but Not Relearning Following Methamphetamine Self-Administration.

Kufahl PR, Hood LE, Nemirovsky NE, Barabas P, Halstengard C, Villa A, Moore E, Watterson LR, Olive MF.

Front Pharmacol. 2012 Nov 26;3:194. doi: 10.3389/fphar.2012.00194. eCollection 2012.

50.

Ethanol pre-exposure during adolescence or adulthood increases ethanol intake but ethanol-induced conditioned place preference is enhanced only when pre-exposure occurs in adolescence.

Carrara-Nascimento PF, Olive MF, Camarini R.

Dev Psychobiol. 2014 Jan;56(1):36-48. doi: 10.1002/dev.21089. Epub 2012 Nov 5.

PMID:
23129501

Supplemental Content

Loading ...
Support Center